Ignite Creation Date:
2025-12-24 @ 1:52 PM
Ignite Modification Date:
2026-02-05 @ 11:47 PM
Study NCT ID:
NCT06250595
Status:
RECRUITING
Last Update Posted:
2024-02-09
First Post:
2023-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
European Rare Blood Disorders Platform (ENROL)
Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anemia | View |
| None | Bone Marrow Failure | View |
| None | Bleeding Disorder | View |
| None | Iron Metabolism Disorders | View |
| None | Myeloma | View |
| None | Lymphoid Neoplasm | View |
| None | Myeloma, Malignant | View |
| None | Leukemia | View |
| None | Anemia, Sickle Cell | View |
| None | Thalassemia | View |
| None | Blood Cancer | View |
| None | Red Cell Membrane and Enzyme Abnormalities | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Anemia | View |
| None | Bone Marrow Failure | View |
| None | Bleeding disorder | View |
| None | Iron metabolism disorder | View |
| None | Myeloid | View |
| None | Lymphoid | View |
| None | Blood cancer | View |
| None | Leukemia | View |
| None | Red Cell membrane and Enzyme Abnormalities | View |
| None | Thalassemia | View |
| None | Sickle Cell Disease | View |